Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Oncology Group Stories

2014-04-07 12:22:52

The Hyundai Hope On Wheels COG Biorepository will help Project:EveryChild study every type of pediatric cancer that occurs in the U.S. FOUNTAIN VALLEY, Calif., April 7, 2014 /PRNewswire/ -- Hyundai Motor America's pediatric cancer nonprofit organization, Hyundai Hope On Wheels®, yesterday announced a $2 million research grant award to fund the Children's Oncology Group's (COG) Project:EveryChild. This marks Hyundai's latest move in supporting the scientific community's efforts to...

2013-10-09 08:29:03

EXTON, Pa., Oct. 9, 2013 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that the Children's Oncology Group (COG) has opened enrollment in a Phase 1 clinical study with MORAb-004 in pediatric patients with relapsed/refractory solid tumors. The open-label Phase 1 study will assess the safety, tolerability and pharmacokinetics of MORAb-004 administered in weekly intravenous infusions in pediatric patients. MORAb-004 is an investigational monoclonal...

2013-01-20 12:20:17

St. Jude Children's Research Hospital scientists lead a study that finds new genetic defects in high-risk childhood leukemia subtypes with chromosomal loss and evidence that some patients have an inherited cancer syndrome MEMPHIS, Tenn., Jan. 20, 2013 /PRNewswire-USNewswire/ -- Research led by St. Jude Children's Research Hospital scientists has identified a possible lead in treatment of two childhood leukemia subtypes known for their dramatic loss of chromosomes and poor treatment...

2012-08-13 06:25:12

Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer MEMPHIS, Tenn., Aug. 13, 2012 /PRNewswire-USNewswire/ -- Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. The study focused on a subtype of...

2011-06-10 13:24:02

Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. What's more, a separate, but related study, found that urologists were less likely than radiation oncologists to recommend adjuvant radiation therapy or to believe it improves overall...

2010-06-21 06:00:00

For 10th Year, CureSearch's 'Reach the Day' Event Brings Hundreds to Washington WASHINGTON, June 21 /PRNewswire-USNewswire/ -- Today and tomorrow hundreds of families of children with cancer are visiting Capitol Hill to ask Congress one question: Where is the research money that was authorized by the Caroline Pryce Walker Conquer Childhood Cancer Act of 2008? For the last 10 years, the CureSearch for Children's Cancer community has come to Washington seeking more federal funding for...

2009-06-22 09:36:00

- In a First, Immunotherapy Works Against Neuroblastoma - PHILADELPHIA, June 22 /PRNewswire-USNewswire/ -- A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system. John M. Maris, M.D., chief of Oncology at The Children's Hospital of Philadelphia, co-authored the phase 3 clinical trial, which was led by Alice Yu, M.D.,...